Atlas Trials

Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects

Clinical trial NCT00567034 · COMPLETED

Trial details

NCT number
NCT00567034
Sponsor
Mclean Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SchizophreniaPsychotic Disorders
Start date
2006-12-01
Primary completion
2010-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.